case_images: PMC11767021_01
case_images: Before treatment (A-C), immediately after the first treatment (D-F), and after two years without other treatments (G-I).
case_images: medicina-61-00084-g004.jpg
case_images: PMC11767021_01_medicina-61-00084-g004.jpg
case_images: medicina-61-00084-f004
case_images: The treatment was performed with lip filler with APAG (Figure 4).
case_images: Before treatment, 13 December 2014 (A-D), and after three treatments, 24 March 2015 (E-H).
case_images: medicina-61-00084-g005.jpg
case_images: PMC11767021_01_medicina-61-00084-g005.jpg
case_images: medicina-61-00084-f005
case_images: The treatment was filler with APAG and LP CGF for the lips and zygomatic area and mesotherapy with LP CGF full-face (Figure 5).
case_images: Before (A,B) and immediately after the treatment (C,D) of LPCGF with microneedling. The desired esthetic effect was best achieved through a noticeable reduction in signs of aging and a general improvement in skin texture. In comparison: signs of skin aging in the neck, cheek, and cheekbone area before treatment (E,G,I) and the clear esthetic improvements in the same areas after treatment (F,H-J). Desired final esthetic result achieved of face and neck (K): improvement of skin texture and reduction in wrinkle depth.
case_images: medicina-61-00084-g006c.jpg
case_images: PMC11767021_01_medicina-61-00084-g006c.jpg
case_images: medicina-61-00084-f006
case_images: The treatment was filler with APAG and LP CGF for the lips and zygomatic area and mesotherapy with LP CGF full-face (Figure 6).
case_images: Before treatment (A-D) and 5 days after the first treatment (E-H).
case_images: medicina-61-00084-g007b.jpg
case_images: PMC11767021_01_medicina-61-00084-g007b.jpg
case_images: medicina-61-00084-f007
case_images: The treatment was CGF and microneedling (Figure 7).
case_images: Before (A-C), during the first treatment (D,E), immediately after the first treatment (F-H), after three days (I-K), and after 10 days from the first treatment (L-N). Hyperemia and swelling of the scar area are expected consequences of surgery. Hyperemia, in particular, is due to the use of needling to a depth of 2/3 mm to treat scar fibrosis. These symptoms are temporary, normal, and part of the natural healing process. Over time, the hyperemia and swelling will gradually subside as the tissue heals (D-H). The same patient before (O), after three treatments (P), and after three years, without further treatment (Q).
case_images: medicina-61-00084-g008b.jpg
case_images: PMC11767021_01_medicina-61-00084-g008b.jpg
case_images: medicina-61-00084-f008
case_images: Large post-surgical scar of thyroid carcinoma (40 cm) treated with LP CGF and microneedling in a 32-year-old female patient in good health (Figure 8).
case_images: Before treatment (A,C) and after the second treatment, after 3 weeks (B,D).
case_images: medicina-61-00084-g009b.jpg
case_images: PMC11767021_01_medicina-61-00084-g009b.jpg
case_images: medicina-61-00084-f009
case_images: A 42-year-old female patient, suffering from hypercholesterolemia treated with statins, with melasma, dark or hyperpigmented spots on the forehead and face, treated with LP CGF and microneedling full-face in two sessions 3 weeks apart (Figure 9).